{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:00:38Z","timestamp":1780426838055,"version":"3.54.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["18K15821"],"award-info":[{"award-number":["18K15821"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0237475","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T17:55:22Z","timestamp":1597341322000},"page":"e0237475","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hypovascular tumors developed into hepatocellular carcinoma at a high rate despite the elimination of hepatitis C virus by direct-acting antivirals"],"prefix":"10.1371","volume":"15","author":[{"given":"Kazuaki","family":"Tabu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3847-1065","authenticated-orcid":true,"given":"Seiichi","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Inada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Uto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Saisyoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Hiramine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Imanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohki","family":"Taniyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Toyodome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Ijuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Sakae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Moriuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Kanmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"pone.0237475.ref001","unstructured":"World Health Organization. Hepatitis C fact Sheet World Health Organization 2019 [cited 2020 April 4]. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"issue":"15","key":"pone.0237475.ref002","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"A. Villanueva","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0237475.ref003","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840120409","article-title":"Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus","volume":"12","author":"K Kiyosawa","year":"1990","journal-title":"Hepatology"},{"issue":"2","key":"pone.0237475.ref004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL Recommendations on Treatment of Hepatitis C 2018","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0237475.ref005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/hepr.12393","article-title":"Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy","volume":"45","author":"N Hiramatsu","year":"2015","journal-title":"Hepatol Res"},{"issue":"5","key":"pone.0237475.ref006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"RL Morgan","year":"2013","journal-title":"Annals of internal medicine"},{"issue":"6\u20137","key":"pone.0237475.ref007","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biochi.2007.04.006","article-title":"Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use","volume":"89","author":"M Ferrantini","year":"2007","journal-title":"Biochimie"},{"issue":"1","key":"pone.0237475.ref008","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2012.03.006","article-title":"Pharmacology and therapeutic potential of interferons","volume":"135","author":"PM George","year":"2012","journal-title":"Pharmacol Ther"},{"key":"pone.0237475.ref009","article-title":"The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen","author":"H Innes","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"pone.0237475.ref010","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents","volume":"153","author":"F Kanwal","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0237475.ref011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2017.08.030","article-title":"HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma","volume":"68","author":"GN Ioannou","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"5","key":"pone.0237475.ref012","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1053\/j.gastro.2018.07.015","article-title":"Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs","volume":"155","author":"P Nahon","year":"2018","journal-title":"Gastroenterology"},{"issue":"8724","key":"pone.0237475.ref013","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/0140-6736(90)92768-D","article-title":"Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma","volume":"336","author":"T Takayama","year":"1990","journal-title":"Lancet"},{"issue":"3","key":"pone.0237475.ref014","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cncr.21607","article-title":"Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis","volume":"106","author":"M Kobayashi","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"pone.0237475.ref015","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.12464","article-title":"Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)","volume":"45","author":"N Kokudo","year":"2015","journal-title":"Hepatol Res"},{"issue":"6","key":"pone.0237475.ref016","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"RK Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"pone.0237475.ref017","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00535-016-1303-0","article-title":"New resistance-associated substitutions and failure of dual oral therapy with daclatasvir and asunaprevir","volume":"52","author":"S Mawatari","year":"2017","journal-title":"J Gastroenterol"},{"issue":"6","key":"pone.0237475.ref018","doi-asserted-by":"crossref","first-page":"e0198642","DOI":"10.1371\/journal.pone.0198642","article-title":"The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir","volume":"13","author":"S Mawatari","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"pone.0237475.ref019","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/hepr.13474","article-title":"Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all-oral direct antiviral therapy","volume":"50","author":"S Mawatari","year":"2020","journal-title":"Hepatol Res"},{"issue":"2","key":"pone.0237475.ref020","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1148\/radiol.12112677","article-title":"Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma","volume":"266","author":"T Hyodo","year":"2013","journal-title":"Radiology"},{"issue":"5\u20136","key":"pone.0237475.ref021","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1159\/000355248","article-title":"Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors","volume":"31","author":"T Inoue","year":"2013","journal-title":"Digestive diseases (Basel, Switzerland)"},{"issue":"9","key":"pone.0237475.ref022","doi-asserted-by":"crossref","first-page":"e0163119","DOI":"10.1371\/journal.pone.0163119","article-title":"Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma","volume":"11","author":"S Ogasawara","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"pone.0237475.ref023","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/liv.13987","article-title":"The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study","volume":"39","author":"H Toyoda","year":"2019","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"6","key":"pone.0237475.ref024","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/apt.14914","article-title":"Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments","volume":"48","author":"H Toyoda","year":"2018","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"6","key":"pone.0237475.ref025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12072-018-9895-5","article-title":"Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection","volume":"12","author":"Y Ooka","year":"2018","journal-title":"Hepatology international"},{"issue":"5","key":"pone.0237475.ref026","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jhep.2019.01.005","article-title":"Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules","volume":"70","author":"Z Marino","year":"2019","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0237475.ref027","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/hep.29707","article-title":"The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study","volume":"67","author":"DK Li","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"pone.0237475.ref028","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.29811","article-title":"Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease","volume":"68","author":"LI Backus","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"pone.0237475.ref029","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jhep.2017.05.028","article-title":"Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C","volume":"67","author":"H Nagata","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0237475.ref030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2018.09.029","article-title":"Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy","volume":"70","author":"M Nishibatake Kinoshita","year":"2019","journal-title":"J Hepatol"},{"issue":"4","key":"pone.0237475.ref031","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"M Reig","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"pone.0237475.ref032","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","article-title":"Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals","volume":"65","author":"F Conti","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0237475.ref033","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function","volume":"149","author":"E Serti","year":"2015","journal-title":"Gastroenterology"},{"issue":"12","key":"pone.0237475.ref034","doi-asserted-by":"crossref","first-page":"e0167934","DOI":"10.1371\/journal.pone.0167934","article-title":"DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment","volume":"11","author":"R Villani","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"pone.0237475.ref035","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/hep.29911","article-title":"Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals","volume":"68","author":"F Faillaci","year":"2018","journal-title":"Hepatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T17:56:30Z","timestamp":1597341390000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0237475"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Kanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0237475","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]}}}